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P-cresol, a uremic toxin, decreases endothelial cell response in vivo [2], parathyroid hormone (PTH) inhibits B cell
to inflammatory cytokines. proliferation [3], and polyamines decrease TNF-induced
Background. Infectious diseases are among the most mor- gene expression in endothelial cells [4].bid events in uremia. The uremic toxin p-cresol may play a
It has been suggested that the uremic toxin p-cresolrole in the immunodeficiency of uremia by depressing phago-
(4-methylphenol, molecular weight 108.1 D) plays a rolecyte functional capacity. Leukocyte adhesion to endothelium,
a key event in the immune response, is mediated by endothelial in the immunodeficiency of uremia because it depresses
adhesion molecules. These include intercellular adhesion mole- phagocyte functional capacity [5] and inhibits the release
cule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) of platelet-activating factor (PAF) by macrophages [6].and E-selectin, which are induced by various inflammatory cy-
P-cresol is an end product of protein catabolism. It is atokines. We asked whether p-cresol alters endothelial adhe-
partially lipophilic moiety, which strongly binds to plasmasion molecule expression and modifies endothelial/leukocyte
adhesion. proteins under normal conditions. A part of the unconju-
Methods. Human umbilical vein endothelial cells (HUVEC) gated p-cresol is removed via urine. Furthermore, in
were incubated with p-cresol in the presence or absence of tumor
uremia, modifications in the intestinal flora result in thenecrosis factor (TNF) or interleukin-1 (IL-1). Thereafter,
specific overgrowth of bacteria that are p-cresol produc-the endothelial molecules ICAM-1, VCAM-1, and E-selec-
tin were quantitated and the monocyte (THP-1) adhesion to ers [7]. Plasma concentrations of total p-cresol increase
HUVEC measured. progressively during the development of chronic renal
Results. P-cresol decreased cytokine-induced protein and failure. In uremic patients, serum levels of p-cresol are
mRNA expression of ICAM-1 and VCAM-1. In addition,
increased about tenfold and those of free non-protein-p-cresol significantly decreased the adhesion of THP-1 to cyto-
bound p-cresol are even higher [8].kine-stimulated HUVEC.
Conclusions. P-cresol may play a role in the immune defect Leukocyte adhesion to endothelium is a key event in
of uremic patients by inhibiting cytokine-induced endothe- immune response, since leukocytes have to cross the
lial adhesion molecule expression and endothelium/monocyte endothelial barrier to migrate to the sites of infec-adhesion.
tions. Adhesion molecules of both cell types mediate
leukocyte adhesion to endothelium. Such adhesion mole-
cules include E-selectin, intercellular adhesion mole-
Uremic patients often display an immunodeficiency
cule-1 (ICAM-1), and vascular cell adhesion molecule-1
state, and infection remains one of the major causes of
(VCAM-1) on endothelial cells. E-selectin, a member of
mortality in patients with chronic renal failure (CRF)
the selectin family, is not expressed by resting endothe-
[1]. Studies strongly suggest that uremic toxins are in-
lium. After endothelial stimulation by inflammatory cyto-volved in the impaired immune response of CRF pa-
kines or lipopolysaccharides (LPS), E-selectin is stronglytients. For example, methylguanidine significantly inhib-
and rapidly induced on endothelial surface and thus me-its tumor necrosis factor (TNF) production in vitro and
diates leukocyte rolling on inflamed endothelium. ICAM-1
and VCAM-1 are two members of the immunoglobulin
gene superfamily. They are involved in firm adhesionKey words: endothelium, p-cresol, inflammatory cytokines, adhesion,
uremia, immune defect. of leukocytes to endothelium. ICAM-1 is constitutively
expressed by resting endothelial cells and its expressionReceived for publication April 19, 2001
is strongly enhanced by cytokines. ICAM-1 binds leuko-and in revised form May 16, 2002
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weakly expressed by resting endothelium, is strongly up- second passage on gelatin-coated 6-well or 96-well cul-
ture plates.regulated by inflammatory stimuli. VCAM-1 is a ligand
for VLA-4, an adhesion molecule expressed on lympho-
THP-1 cell culturecytes, monocytes, and eosinophils [9].
To our knowledge, no studies have investigated the The THP-1 cell line was maintained in RPMI 1640
medium with glutamax-1 supplemented with 10% FBS,effect of p-cresol on endothelial adhesion molecules. Since
leukocyte adhesion to endothelium plays a key role in 25 mmol/L Hepes, 100 U/mL penicillin, and 100 g/mL
streptomycin, under standard cell culture conditions.immune response and inflammation, we asked whether
p-cresol altered endothelial adhesion molecule expres-
Immunofluorescence assay and flow cytometry analysission and modified endothelial/leukocyte adhesion.
of cell adhesion molecule expression
P-cresol was diluted from a stock solution at 10 mg/mL
METHODS
prepared in methanol. Endothelial cells were incubated
Reagents and antibodies for 4 or 24 hours in EGM-2 medium containing methanol
1% (control medium) or different concentrations ofP-cresol was obtained from Supelco (Sigma-Aldrich,
Saint Quentin Fallavier, France). Bovine serum albumin p-cresol in the presence or absence of TNF (500 U/mL
or 100 U/mL) or IL-1 (50 U/mL or 10 U/mL). In some(BSA) and sodium azide were purchased from Sigma-
Aldrich and methanol from Carlo Erba (Milano, Italy). experiments, human serum albumin at a final concentra-
tion of 4 g/dL was added in the medium. The concentra-Calcein-AM was obtained from Molecular Probes (Eu-
gene, OR, USA), TNF from Tebu (Le Perray en Yvelines, tions of p-cresol were 100g/mL (10-fold uremic concen-
tration), 10 g/mL (uremic concentration), and 1 g/mLFrance), and interleukin-1 (IL-1) from Boehringer
Mannheim Biochemica (Meylan, France). Monoclonal (normal concentration). Endothelial cell viability, as as-
sessed by trypan blue exclusion, was similar in the differ-antibodies against VCAM-1 (clone 1G11) and E-selectin
(clone 12B6), and irrelevant control IgG were purchased ent experimental conditions and was always 85%.
After incubation, confluent HUVEC monolayers werefrom Immunotech (Marseille, France). Monoclonal anti-
body (mAb) against ICAM-1 (clone F431C2) was ob- detached with a pre-warmed 0.05% trypsin-0.02% EDTA
solution for 30 seconds at 37C. Cells were washed withtained from Biocytex (Marseille, France). FITC-conju-
gated sheep anti-mouse Ig F(ab)2 fraction (Silenus) was PBS-0.1% BSA-0.1% sodium azide (PBS-BSA-AZ) and
incubated with 50 L of monoclonal antibodies (usedfrom Eurobio (Les Ulis, France). QIFIKIT beads were
from Dako (Trappes, France). at previously determined saturating conditions) for 60
minutes at 4C. After washing with PBS-BSA-AZ, cellsEGM-2 medium was purchased from Clonetics Bio-
whittaker (Verviers, Belgium). Phosphate buffered saline were labeled with 100 L of FITC-conjugated sheep
anti-mouse Ig F(ab)2 fraction for 45 minutes at 4C. Af-(PBS), RPMI 1640 medium with glutamax-1, trypsin-
EDTA solution, gelatin, Hepes buffer, and penicillin-strep- ter two additional washing steps, endothelial cells were
analyzed using an Epics XL flow cytometer (Beckman-tomycin were obtained from Life Technologies (Cergy-
Pontoise, France). Fetal bovine serum (FBS) was from Coulter, Roissy, France). Analysis was focused on the
whole cell population, taken for calculation of meanDominique Dutscher (Brumath, France). Human serum
albumin (HSA) solution 20% was obtained from LFB fluorescence intensity. Mean fluorescence intensity was
calculated by the System II software (Beckman-Coulter,(Courtaboeuf, France).
RNeasyMini Kit was obtained from Qiagen (Courta- Roissy, France) and was expressed in arbitrary units.
boeuf, France) and SuperScript One-Step RT-PCR
Quantification assay of cell adhesionwas from Life Technologies (Cergy-Pontoise, France).
molecule expressionFirst Strand cDNA Synthesis Kit for RT-PCR and Taq
DNA polymerase were purchased from Roche (Meylan, Quantification was done with the QIFI assay (quanti-
tative immunofluorescent indirect assay) based on theFrance).
linear relationship between mean fluorescence intensity
Endothelial cell culture (arbitrary units) and number of binding sites of mono-
clonal antibodies (mAb) per cell [11]. The fluorescenceHuman umbilical vein endothelial cells (HUVEC)
were recovered from umbilical cord vein by collagenase intensity measured on the flow cytometer was converted
into number of mAb binding sites per cell by standarddigestion as previously described [10]. Cells were seeded
on gelatin-coated culture flasks and grown in EGM-2 beads from QIFIKIT, including a blank preparation
with no attached murine Ig together with five positivemedium under standard cell culture conditions (humidi-
fied atmosphere, 5% CO2, 37C). Cells were then de- bead samples coated with increasing amounts of murine
IgG. Beads were labeled with the FITC-conjugated sec-tached with a 0.05% trypsin-0.02% ethylenediaminetet-
raacetic acid (EDTA) solution and subcultured to the ondary antibody. A linear regression curve was drawn
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by plotting the mean fluorescence intensity measured on sense primer according to the manufacturer’s instruc-
tions. Serial dilutions of the standard were coamplifiedeach bead sample and the known number of mAb bind-
ing sites per cell for each bead. The mean fluorescence with 2 L of the RT product (1/10 of the RT reaction)
and with the sense 1 and antisense primers. In brief, 68,intensity obtained for each antibody corrected for iso-
type control values was converted with the standard 34, 17, 3.4 and 1.7 pg of ICAM-1 standard were mixed
with 2 L of the RT product in a 100 L reaction volumecurve equation into the corresponding number of mAb
binding sites per cell. Endothelial cells were considered containing 10 pmol of each primer, 0.2 mmol/L of each
dNTP, and one unit of taq DNA polymerase. The ther-positive when they expressed more than 5000 mAb bind-
ing sites per cell. mal cycling reactions were denaturation at 94C for 30
seconds, annealing at 60C for 45 seconds, and extension
RNA extraction from HUVEC at 72C for 30 seconds (for a total of 35 cycles), followed
by a termination step at 72C for 10 minutes. The PCREndothelial cells were incubated in EGM-2 medium
containing methanol 1% (control), or p-cresol at 10 products were subjected to 1.5% agarose gels, and the
intensity of the ethidium bromide staining for each bandg/mL or at 100 g/mL, in the presence or absence of
TNF (500 U/mL) or IL-1 (50 U/mL). After 16 hours was densitometrically measured with the Scion Image
software (Scion Corporation, Frederick, MD, USA). Theof incubation, confluent HUVEC monolayers were de-
tached with a pre-warmed 0.05% trypsin-0.02% EDTA logarithm of the ratio (PCR product standard/target)
was plotted versus the logarithm of the amount (pg) ofsolution for 30 seconds at 37C. Cells were stored at
80C for further RNA extraction. the standard used in the assay. The amount of ICAM-1
cDNA produced by the RT reaction could be read fromTotal RNA was extracted from HUVEC by an RNea-
sy mini kit, and the RNA concentrations were deter- the point of the curve where amplifications of standard
and target were equal.mined by spectrophotometric measurements at 260 nm
wavelength. The same method was used to determine the GAPDH
mRNA levels in these total RNA preparations. The primerTwo micrograms of total RNA of each sample was
subjected to electrophoresis through 1% agarose gel con- sequences are the following: 5-GTCAGTGGTGGAC
CTGA CCTG-3 for the sense 1 primer, 5-GTCAGTGGtaining formaldehyde and visualized by ethidium bro-
mide staining. TGGACCTGACCTGATTTGGCTACAGC AACAG
GGTG-3 for the sense 2 primer, and 5-TGAGGAGG
Reverse transcriptase-polymerase chain reaction GGAGATTCAGTG-3 for the antisense primer. The
analysis of ICAM-1 and VCAM-1 mRNA GAPDH standard was 190 bp in length versus 400 bp
for the endogenous GAPDH sequences. Total RNA (125Competitive RT-PCR for ICAM-1 mRNA analysis. To
analyze ICAM-1 mRNA levels by competitive reverse ng) was reverse transcribed with the First Strand cDNA
Synthesis Kit for RT-PCR and GAPDH antisense primer.transcription-polymerase chain reaction (RT-PCR), as
previously described [12] an internal standard was con- Then, 2 L (1/10) of the RT product was coamplified
with 960, 480, 192, 96, and 48 fg of GAPDH standardstructed that shares the same primer pair as the endoge-
nous ICAM-1 sequences and can be distinguished by a and with the sense 1 and antisense GAPDH primers. The
thermal cycling reactions were the same as for ICAM-1lower size. First, the sense 1 (5-GTCCCCCTCAAAAG
TCATCCT-3) and antisense (5-CCGAGGTGTTCT mRNA analysis. The PCR products subjected to 1.5%
agarose gel were analyzed as described below. The valuesCAAACAGCT-3) primers were used to amplify a 581
bp ICAM-1 cDNA. An aliquot of this PCR was then obtained for GAPDH signals were used to normalize
those for ICAM-1 signals.amplified with the same antisense primer and a second
sense 2 primer (5-AAAGTCATCCTTACTGGACTC Semiquantitative RT-PCR for VCAM-1 mRNA analy-
sis. VCAM-1 mRNA levels were analyzed by semiquan-CAGAACGGGT-3) containing in its 5-end the first
10 nucleotides of the 3 part of the sense 1 primer (under- titative RT-PCR. Both cDNA synthesis and PCR were
performed in a single tube with the SuperScript One-lined in the sequence of the sense 2 primer). Finally, an
aliquot of the second PCR was amplified with the sense 1 Step RT-PCR kit according to the manufacturer’s in-
structions. The primer sequences were the following: senseand antisense 1 to produce the internal standard, 307 bp
in length. Thus, the internal standard was differentiated 5-CCCTTGACCGGCTGGAGATTG-3 and antisense
5-CTGTGTCTCCTGTCTCC GCTT-3 for VCAM-1from the ICAM-1 cDNA sequence by size (307 vs.
581 bp) and could be amplified with the same primers. (the VCAM-1 cDNA obtained was 638 bp in length) and
sense 5-GAGTCAACGGATTTGGTCGT-3 and anti-This standard was purified on a 1.5% agarose gel, and
its concentration was determined by spectrophotometric sense 5-TTGATTTTGGAGGGATC-3; for GAPDH
(the GAPDH cDNA was 238 bp in length). The linearitymeasurements at 260 nm wavelength.
Total RNA (125 ng) was reverse transcribed with the of the amplification was determined for cycle number and
RNA concentrations in preliminary experiments. ForFirst Strand cDNA Synthesis Kit for RT-PCR and anti-
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Fig. 1. Effects of p-cresol (pc) on intercellular adhesion molecule-1
(ICAM-1) expression on human umbilical vein endothelial cells (HUVEC) Fig. 2. Effects of p-cresol (pc) on VCAM-1 expression on HUVEC
stimulated with tumor necrosis factor (TNF; A) or interleukin-1 (IL-1; stimulated with TNF (A) or IL-1 (B). Endothelial cells were incubated
B). Endothelial cells were incubated for 24 hours in medium (control), for 24 hours in medium (control), TNF (500 U/mL), or IL-1 (50 U/mL)
TNF (500 U/mL), or IL-1 (50 U/mL) in the presence or absence in the presence or absence of different concentrations of p-cresol. After
of different concentrations of p-cresol. After incubation, endothelial incubation, endothelial expression of VCAM-1 was analyzed by flow cy-
expression of ICAM-1 was analyzed by flow cytometry after indirect im- tometry after indirect immunofluorescence staining. Data are expressed
munofluorescence staining. Data are expressed as mean  SEM of 6 as mean  SEM of 6 independent experiments. ••P  0.01 vs. TNF,
independent experiments. ••P  0.01 vs. TNF, *P  0.05 vs. IL-1. •••P  0.001 vs. TNF, ***P  0.001 vs. IL-1.
VCAM-1 mRNA analysis, 50 ng and 12.5 ng of total Table 1. Effects of p-cresol on ICAM-1, VCAM-1 and
E-selectin expression on cytokine-stimulated HUVECRNA were chosen for IL-1 and TNF stimulation, re-
after a 4-hour incubationspectively. The thermal cycling reactions were denatur-
ICAM-1 VCAM-1 E-selectination at 94C for 30 seconds, annealing at 58C for 45
seconds, and extension at 72C for 30 seconds (for a total Control 288 52 42
TNF 41864 897 15025of 20 cycles), followed by a termination step at 72C for
TNF 	 pc 10 lg/mL 30325a 686b 13727
10 minutes. For GAPDH mRNA, the amount of total TNF 	 pc 100 lg/mL 28729a 565c 13927
IL-1 11618 589 27412RNA was 6 ng and the thermal cycling reactions were
IL-1 	 pc 10 lg/mL 7910f 395d 26919denaturation at 94C for 30 seconds, annealing at 60C IL-1 	 pc 100 lg/mL 6814f 347e 25416
for 45 seconds, and extension at 72C for 30 seconds
Endothelial cells were incubated for 4 hours in medium (control), tumor
necrosis factor (TNF 500 U/mL), or interleukin-1 (IL-1 50 U/mL) in presence(for a total of 25 cycles). The RT-PCR products were
or absence of different concentrations of p-cresol (pc). After incubation, endothe-subjected to 1.5% agarose gels. The intensity of the lial expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhe-
sion molecule-1 (VCAM-1), and E-selectin was analyzed by flow cytometryethidium bromide staining for each band was densito-
after indirect immunofluorescence staining. Results are expressed as number of
metrically measured with the Scion Image software. All binding sites of mAb per cell divided by 103. Data are expressed as mean 
SEM of 7 independent experiments.VCAM-1 signals were normalized with GAPDH signals a P  0.05, b P  0.01, c P  0.001 vs. TNF
d P  0.05, e P  0.01, f P  0.001 vs. IL-1and the results were expressed in arbitrary units.
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Fig. 3. Effects of p-cresol (pc) on ICAM-1 expression on HUVEC Fig. 4. Effects of p-cresol (pc) on VCAM-1 expression on HUVEC
stimulated with lower doses of TNF (A) or IL-1 (B). Endothelial cells stimulated with lower doses of TNF (A) or IL-1 (B). Endothelial cells
were incubated for 24 hours in medium (control), TNF (100 U/mL), were incubated for 24 hours in medium (control), TNF (100 U/mL), or
or IL-1 (10 U/mL) in the presence or absence of different concentra- IL-1 (10 U/mL) in the presence or absence of different concentrations
tions of p-cresol. After incubation, endothelial expression of ICAM-1 of p-cresol. After incubation, endothelial expression of VCAM-1 was
was analyzed by flow cytometry after indirect immunofluorescence analyzed by flow cytometry after indirect immunofluorescence staining.
staining. Data are expressed as mean  SEM of 6 independent experi- Data are expressed as mean  SEM of 6 independent experiments.
ments. •••P  0.001 vs. TNF, *P  0.05 vs. IL-1, **P  0.01 vs. IL-1. •P  0.05 vs. TNF, •••P  0.001 vs. TNF, **P  0.01 vs. IL-1, *** P 
0.001 vs. IL-1.
Adhesion assay of THP-1 to HUVEC
ent THP-1 cells were removed by three washings, andEndothelial cells cultured in 96-well plates were incu-
culture medium was added to each well. The remainingbated for 24 hours in EGM-2 medium containing differ-
fluorescence (Fx) and the fluorescence of the blank (Fb2)ent concentrations of p-cresol or containing methanol
were measured, and percentage adhesion was calculated1% (control), in the presence or absence of TNF (500
by the following formula:U/mL) or IL-1 (50 U/mL).
THP-1 cells were washed with RPMI medium and % adhesion 
 [(Fx  Fb2)/(Ft  Fb1)]  100
labeled with 10 mol/L Calcein-AM at 37C during 30
Fluorescence was determined by the Cytofluor Se-minutes. After three washes in RPMI, THP-1 cells were
ries 4000 Fluorescence multi-well plate reader (PerSep-suspended in culture medium at 37C at a concentration
tive Biosystems, Framingham, MA, USA). The excita-of 106/mL. Cell viability assessed by trypan blue exclusion
tion filter was a 20 nm bandwidth centered at 485 nmwas greater than 90%.
and the emission filter was a 25 nm bandwidth centeredAdhesion of THP-1 to HUVEC was measured with
at 530 nm. This method yielded low variation betweenthe method of Vaporcyian, Jones and Ward [13]. One
replicates.hundred microliters of THP-1 (106/mL) were added on
washed HUVEC in triplicate and incubated for 30 min-
Statistical analysisutes at 37C in 5% CO2 atmosphere. Culture medium
Data are expressed as mean  standard error of thealone was used as a blank. Total fluorescence (Ft) and
fluorescence of blank (Fb1) were measured. Non-adher- mean (SEM) of a minimum of three independent experi-
Dou et al: P-cresol, cytokines and endothelial cells2004
Fig. 5. Effects of p-cresol (pc) on ICAM-1 expression on HUVEC
stimulated with TNF (A) or IL-1 (B) in presence of human serum Fig. 6. Effects of p-cresol (pc) on VCAM-1 expression on HUVEC
albumin (HSA) at 4 g/dL. Endothelial cells were incubated for 24 hours stimulated with TNF (A) or IL-1 (B) in presence of HSA at 4 g/dL.
in medium supplemented with 4 g/dL HSA (control), TNF (500 U/mL), Endothelial cells were incubated for 24 hours in medium supplemented
or IL-1 (50 U/mL) in presence or absence of different concentrations with 4 g/dL HSA (control), TNF (500 U/mL), or IL-1 (50 U/mL) in
of p-cresol. After incubation, endothelial expression of ICAM-1 was the presence or absence of different concentrations of p-cresol. After
analyzed by flow cytometry after indirect immunofluorescence staining. incubation, endothelial expression of VCAM-1 was analyzed by flow
Data are expressed as mean  SEM of 5 independent experiments. cytometry after indirect immunofluorescence staining. Data are ex-
••P  0.01 vs. TNF, *P  0.05 vs. IL-1, ***P  0.001 vs. IL-1. pressed as mean  SEM of 5 independent experiments. •P  0.05 vs.
TNF, •••P  0.001 vs. TNF, *P  0.05 vs. IL-1, ***P  0.001 vs. IL-1.
ments. Statistical analysis was performed with the Prism
increase in ICAM-1 and VCAM-1 expression on endo-software (GraphPad Software Inc., San Diego, CA, USA).
thelial surface (Figs. 1 and 2). The increase in ICAM-1Determination of significant differences was performed
expression induced by TNF was inhibited by 27% by 10by repeated measures analysis of variance (ANOVA)
g/mL of p-cresol (Fig. 1). Similar results were obtainedfollowed by a Tukey’s test. A P value lower than 0.05
with IL-1 (Fig. 1). P-cresol at 100 g/mL also inhibitedwas considered significant.
ICAM-1 expression on cytokine-stimulated HUVEC but
did not induce a stronger inhibition than p-cresol at 10
RESULTS
g/mL (Fig. 1). P-cresol at 1 g/mL (healthy subject con-
P-cresol down-regulates cytokine-induced expression centration) did not significantly modify cytokine-induced
of endothelial adhesion molecules ICAM-1 expression on HUVEC (Fig. 1). The increase
in VCAM-1 expression was also inhibited by p-cresol;Endothelial cells were incubated in medium with or
VCAM-1 induction by TNF and IL-1 was decreasedwithout different concentrations of p-cresol, in presence
42% and 49%, respectively, by p-cresol at 10 g/mLor absence of TNF (500 U/mL) or IL-1 (50 U/mL).
(Fig. 2). VCAM-1 expression on cytokine-stimulatedAfter 24 hours, ICAM-1 and VCAM-1 expression on en-
HUVEC also was inhibited by p-cresol at 100 g/mL;dothelial cell surface was measured by flow cytometry.
P-cresol alone had no effect on endothelial adhesion mole- with TNF, this inhibition was stronger than with p-cresol
at 10 g/mL. VCAM-1 induction by TNF was decreasedcule expression whatever the dose used (not shown). Af-
ter a 24-hour incubation, TNF and IL-1 induced a strong by 56% by p-cresol at 100 g/mL (Fig. 2). P-cresol at
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1 g/mL had no effect on cytokine-induced VCAM-1
expression on HUVEC (Fig. 2).
Inhibition of cytokine-induced expression of ICAM-1
and VCAM-1 occurred rapidly, since the surface expres-
sion of these molecules also was inhibited by p-cresol
after a four-hour incubation (Table 1).
Endothelial cells were stimulated with lower amounts
of TNF and IL-1 (100 U/mL and 10 U/mL, respec-
tively), and the inhibitory effect of p-cresol on cytokine-
induced adhesion molecule expression was similar (Figs. 3
and 4). The increase in ICAM-1 expression induced by
TNF at 100 U/mL was inhibited 22% and 23% by 10
g/mL and 100 g/mL of p-cresol, respectively (Fig. 3).
VCAM-1 induction by TNF at 100 U/mL was decreased
38% and 49% by p-cresol at 10 g/mL and 100 g/mL,
respectively (Fig. 4). Similar results were obtained with
IL-1 at 10 U/mL (Figs. 3 and 4).
E-selectin was analyzed at its maximal level of surface
expression, that is, after a four-hour incubation (Table 1).
E-selectin expression on HUVEC incubated with TNF at
500 U/mL or IL-1 at 50 U/mL was strongly increased
relative to control. Cytokine-induced E-selectin expres-
sion was not inhibited by p-cresol, whatever the dose
(Table 1).
Since p-cresol is protein-bound, the influence of albu-
min concentration on adhesion molecule expression was
analyzed. The albumin concentration in the usual culture
medium was 0.08 g/dL. HSA was added to the culture me-
dium at a concentration of 4 g/dL. At this albumin con-
centration, an inhibition of cytokine-induced expression
of adhesion molecules was caused by p-cresol (Figs. 5
Fig. 7. Effects of p-cresol (pc) on ICAM-1 mRNA level in HUVEC
and 6). This inhibition was lower than that obtained with stimulated with IL-1 (A) or TNF (B). Endothelial cells were incubated
for 16 hours in control medium, IL-1 (50 U/mL), or TNF (500 U/mL)medium not supplemented with albumin: TNF-induced
in the presence or absence of p-cresol. Total RNA was then isolatedICAM-1 expression was inhibited 22% and 23% by
and ICAM-1 and GAPDH mRNA levels were analyzed by competitive
p-cresol at 10 g/mL and 100g/mL, respectively (Fig. 5); RT-PCR as described in the Methods section. Intensities of the ethidium
bromide staining of RT-PCR products subjected to 1.5% agarose gelTNF-induced VCAM-1 expression was inhibited 20%
were quantified with the Scion Image software. GAPDH signals wereand 36% by p-cresol at 10 g/mL and 100 g/mL, re-
used to normalize ICAM-1 signals. Data are expressed as mean SEM
spectively (Fig. 6). Similar results were obtained with of 3 independent experiments. *P  0.05 vs. IL-1, •P  0.05 vs. TNF.
IL-1–induced adhesion molecule expression (Figs. 5
and 6). P-cresol at 1 g/mL did not modify cytokine-
induced adhesion molecule expression in these condi-
(Fig. 8A, lanes 3 and 6) mRNA. The increase in ICAM-1tions (Figs. 5 and 6).
and VCAM-1 mRNA induced by IL-1 was inhibited
P-cresol inhibits cytokine-induced mRNA of by p-cresol at 10 g/mL and 100 g/mL (Figs. 7A, 8A
endothelial adhesion molecules lanes 4 and 5, and 8B). Similar results were obtained
when IL-1 was replaced by TNF (Figs. 7B, 8A lanes 7To explore the mechanisms responsible for inhibition
and 8, and 8C).of ICAM-1 and VCAM-1 expression, we studied ICAM-1
and VCAM-1 mRNA levels by RT-PCR. These experi-
P-cresol reduces cytokine-induced THP-1 adhesion toments were performed only with p-cresol concentrations
endothelial cellsinducing an inhibition of adhesion molecule expression,
To determine the functional importance of the inhibi-that is, 10 g/mL and 100 g/mL. P-cresol did not in-
tory properties of p-cresol on stimulated expression ofcrease ICAM-1 (Fig. 7) and VCAM-1 (Fig. 8, lanes 1
endothelial adhesion molecules, we studied the adhesionand 2) mRNA levels in the absence of inflammatory
of THP-1 monocytes to HUVEC. The stimulation ofstimuli. Stimulation of HUVEC with IL-1 or TNF re-
sulted in a strong increase in ICAM-1 (Fig. 7) and VCAM-1 HUVEC by TNF or IL-1 resulted in a sixfold increase
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Fig. 8. Effects of p-cresol (pc) on VCAM-1
mRNA level in HUVEC stimulated with IL-1
or TNF. Endothelial cells were incubated for
16 hours in control medium, IL-1 (50 U/mL),
or TNF (500 U/mL), in the presence or ab-
sence of p-cresol. After incubation, VCAM-1
and GAPDH mRNA levels in HUVEC were
analyzed by semiquantitative RT-PCR. (A)
UV-illuminated gel electrophoresis from a
representative experiment. (B and C ) The
mean  SEM of band intensities of VCAM-1
cDNA from 5 independent experiments, after
normalization with the intensities of GAPDH
cDNA. The results are expressed in arbitrary
units. **P  0.01 vs. IL-1, ***P  0.001 vs.
IL-1, •P  0.05 vs. TNF, ••P  0.01 vs. TNF.
in THP-1 adhesion (Fig. 9); treatment with p-cresol alone of endothelial adhesion molecules. We investigated the
effects of p-cresol on endothelial adhesion moleculesdid not modify THP-1 adhesion, whatever the dose of
during cytokine stimulation, since most of the endothe-p-cresol used (not shown). Incubation with p-cresol sig-
lial molecules mediating leukocyte adhesion are stronglynificantly reduced THP-1 adhesion to cytokine-stimu-
inducible.lated HUVEC. P-cresol at 10 g/mL decreased mono-
The results demonstrated that p-cresol significantlycyte adhesion to TNF and IL-1–stimulated HUVEC
inhibited cytokine-stimulated expression of endothelialby 25% and 42%, respectively (Fig. 9). P-cresol at 100
adhesion molecules ICAM-1 and VCAM-1. P-cresol aloneg/mL also strongly decreased monocyte adhesion to
had no effect on endothelial adhesion molecule expres-stimulated HUVEC (Fig. 9). P-cresol at 1 g/mL had
sion. Cell adhesion molecules were inhibited at a p-cresolno effect on monocyte adhesion to TNF-stimulated
concentration similar to that in uremic plasma [8, 18].HUVEC, but slightly decreased monocyte adhesion to
On the contrary, p-cresol at concentrations observed inIL-1–stimulated HUVEC (Fig. 9).
the plasma of healthy subjects had no notable effect
on induction of endothelial adhesion molecules. At the
DISCUSSION transcriptional level, the mRNA levels of VCAM-1 and
Upon appropriate stimulation, the endothelium exhib- ICAM-1 decreased when cytokine-stimulated endothe-
its increased adhesiveness for leukocytes. Increased ex- lial cells were exposed to p-cresol.
pression of endothelial-leukocyte adhesion molecules (such Since p-cresol is protein-bound in plasma, the culture
as ICAM-1, VCAM-1 and E-selectin) mediates such en- medium was supplemented with albumin at a concentra-
hanced adhesive interactions [14, 15]. Inflammatory cyto- tion found in human plasma. In the presence of albumin,
kines and leukocyte-specific chemoattractants also con- p-cresol inhibited cytokine-induced adhesion molecule
tribute to leukocyte recruitment during inflammatory and expression, but to a lesser extent than in medium not
immune responses [16, 17]. Since p-cresol plasma levels supplemented with albumin. This could be explained by
are enhanced in CRF patients and since p-cresol may the decrease of the free non-protein bound fraction of
play a role in the immunodeficiency of uremia, we hy- p-cresol in medium. It is difficult to extrapolate these in
vitro results to the in vivo situation. However, they showpothesized that p-cresol could modulate the expression
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Other transcription factors must assemble with NF-B
to generate unique transcriptional activating complexes.
For example, the high mobility group (HGM) protein
I(Y) is required for cytokine-induced E-selectin expres-
sion, and the transcriptional activator interferon regula-
tory factor-1 (IRF-1) cooperates with NF-B to mediate
cytokine induction of VCAM-1 [19]. On cytokine stimu-
lated endothelial cells, p-cresol inhibited ICAM-1 and
VCAM-1 up regulation, but not E-selectin induction,
suggesting that p-cresol acts preferentially on ICAM-1
and VCAM-1. It remains unclear how p-cresol inhibits
cytokine-stimulated VCAM-1 and ICAM-1 expression
without inhibiting E-selectin expression. One possible
mechanism is that p-cresol acts on transcriptional factors
involved in VCAM-1 and ICAM-1 induction but not in
E-selectin induction. In addition, stimulated levels of
VCAM-1 transcript are reduced in the presence of the
protein synthesis inhibitor cycloheximide [19], indicating
that protein synthesis is necessary for maximal transcrip-
tional activation. In contrast, E-selectin is superinduced
in the presence of the protein synthesis inhibitor [19].
Hence, another possible mechanism is that p-cresol in-
hibits the synthesis of proteins necessary for VCAM-1
mRNA induction.
The molecular mechanisms of p-cresol action on endo-
thelial cells are not known. A marked impairment of
ICAM-1 mRNA expression was shown in TNF-stimu-
lated endothelial cells depleted of intracellular glutathi-
one [20]. In addition, previous experiments on rat liver
cells demonstrated that p-cresol depletes intracellular
glutathione levels and causes toxicity via the formation
of a reactive intermediate that can be trapped with gluta-
Fig. 9. Effects of p-cresol (pc) on THP-1 adhesion on HUVEC stimu- thione [21]. Therefore, we speculate that p-cresol maylated with TNF (A) or IL-1 (B). Endothelial cells were incubated for
act on endothelial cells by modifying intracellular endo-24 hours in medium (control), TNF (500 U/mL), or IL-1 (50 U/mL)
supplemented or not with different concentrations of p-cresol. After thelial glutathione levels. Further studies are necessary
incubation, THP-1 cells labeled with calcein-AM were added, and to confirm this hypothesis.THP-1 adhesion to endothelial cells was analyzed. Data are expressed
Since leukocyte adhesion to endothelium is one of theas mean SEM of 10 independent experiments for TNF and 7 indepen-
dent experiments for IL-1. ••P  0.01 vs. TNF, *P  0.05 vs. IL-1, key events in immune responses, we studied monocyte
***P  0.001 vs. IL-1. adhesion to endothelial cells. P-cresol alone had no effect
on monocyte adhesion to non-stimulated endothelial
cells. On the other hand, uremic levels of p-cresol sig-
nificantly reduced monocyte adhesion to cytokine-stimu-that at a uremic concentration, and in presence of albu-
min at concentration found in human plasma, p-cresol lated endothelial cells. Hence, the decrease by p-cresol of
adhesion molecule expression on stimulated endothelialhas an effect on endothelial cells.
The three endothelial adhesion molecules have differ- cells is of functional importance because it results in an
inhibition of monocyte adhesion to these endothelial cells.ent patterns of expression and are functionally distinct.
E-selectin mediates the initial leukocyte rolling on endo- The functional state of leukocytes obtained from un-
dialyzed uremic patients or during a dialysis session isthelium whereas ICAM-1 and VCAM-1 mediate firm
adhesion by interacting with integrins on the leukocyte impaired [22–27]. P-cresol may be involved in uremic
leukocyte functional deficiency since it depresses thesurface. The expression of endothelial adhesion mole-
cules is strongly up-regulated by TNF and IL-1 at the phagocyte functional capacity [5] and inhibits the release
of PAF by macrophages [6]. In the present study, wetranscriptional level through the activation of the NF-B
system. Although the endothelial NF-B transcription demonstrated that p-cresol also has a harmful effect on
leukocyte/endothelial cell interactions.factor system is necessary for cytokine-induced endothe-
lial adhesion molecule expression, it is not sufficient. Only 30% of p-cresol is removed by hemodialysis ther-
Dou et al: P-cresol, cytokines and endothelial cells2008
4. Bradley JR, Johnson DR, Pober JS: Four different classes ofapies, which eliminate over 70% of urea and creatinine
inhibitors of receptor-mediated endocytosis decrease tumor necro-
[28], probably because most p-cresol is protein-bound. sis factor-induced gene expression in human endothelial cells.
J Immunol 150:5544–5555, 1993No difference in p-cresol removal was found between
5. Vanholder R, De Smet R, Waterloos MA, et al: Mechanisms ofsynthetic and cellulosic membranes, or low flux and high
uremic inhibition of phagocyte reactive species production: Char-
flux membranes [28]. Whereas dialyzers containing mem- acterization of the role of p-cresol. Kidney Int 47:510–517, 1995
6. Wratten ML, Tetta C, De Smet R, et al: Uremic ultrafiltratebranes with a larger pore size remove middle molecules
inhibits platelet-activating factor synthesis. Blood Purif 17:134–better, a larger pore size has no effect on the removal of
141, 1999
protein-bound uremic toxins such as p-cresol. Therefore, 7. Vanholder R, De Smet R, Lesaffer G: p-cresol: A toxin revealing
many neglected but relevant aspects of uraemic toxicity. Nephrolother solutions should be developed to remove p-cresol,
Dial Transplant 12:2813–2815, 1999such as dialysis membranes with higher adsorption. An
8. De Smet R, David F, Sandra P, et al: A sensitive HPLC method
alternative solution is to reduce the intestinal load of for the quantification of free and total p-cresol in patients with
chronic renal failure. Clin Chim Acta 278:1–21, 1998p-cresol, for example with the uptake of the oral sorbent
9. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion mole-AST-120 [29, 30].
cules. Blood 84:2068–2101, 1994
Endothelial alteration in uremia has previously been 10. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of
human endothelial cells derived from umbilical veins. Identifica-demonstrated in vivo and in vitro. In CRF patients, endo-
tion by morphologic and immunologic criteria. J Clin Invest 52:thelium-dependent vasodilation is altered [31], and plasma
2745–2756, 1973
levels of soluble endothelial molecules [32–35] are in- 11. Poncelet P, Carayon P: Cytofluorometric quantification of cell-
surface antigens by indirect immunofluorescence using monoclonalcreased. In vitro, uremic medium modifies endothelial
antibodies. J Immunol Methods 85:65–74, 1985functions [36–38], and uremic toxins induce endothelial
12. Bonod-Bidaud C, Giraud S, Mandon G, et al: Quantification of
alteration. Homocysteine alters the expression of multi- OXPHOS gene transcripts during muscle cell differentiation in
patients with mitochondrial myopathies. Exp Cell Res 246:91–97,ple genes in endothelial cells [39], oxalate inhibits endo-
1999thelial cell replication and migration [40], and AGEs in-
13. Vaporcyian AA, Jones ML, Ward PA: Rapid analysis of leuko-
crease endothelial permeability [41] and up-regulate the cyte-endothelial cell adhesion. J Immunol Methods 159:93–100, 1993
14. Springer TA: Adhesion receptors of the immune system. Natureexpression of endothelial adhesion molecules [42]. The
346:425–434, 1990present study revealed that p-cresol is a new uremic toxin
15. Imhof BA, Dunon D: Leukocyte migration and adhesion. Adv
that plays a role in endothelial alterations in uremia. The Immunol 58:345–416, 1995
16. Doherty DE, Downey GP, Worthen GS, et al: Monocyte reten-in vitro effect of p-cresol is just the opposite of the effect
tion and migration in pulmonary inflammation. Requirement forof AGEs. This suggests that the various compounds cir-
neutrophils. Lab Invest 59:200–213, 1988
culating in the plasma of uremic patients may either 17. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Prop-
erties of the novel proinflammatory supergene “intercrine” cyto-amplify the recruitment of inflammatory cells or prevent
kine family. Annu Rev Immunol 9:617–648, 1991the recruitment of immunologic competent cells.
18. Niwa T: Phenol and p-Cresol accumulated in uremic serum
In conclusion, we demonstrate that p-cresol inhibits measured by HPLC with fluorescence detection. Clin Chem 39:
both cytokine-induced expression of endothelial adhe- 108–111, 1993
19. Collins T, Read MA, Neish AS, et al: Transcriptional regulationsion molecules and stimulated monocyte adhesion to
of endothelial cell adhesion molecules: NF-kappa B and cytokine-endothelial cells. Since leukocyte adhesion to vascular inducible enhancers. FASEB J 9:899–909, 1995
endothelial cells is a critical process in defense mecha- 20. Kefer J, Rahman A, Anwar KN, Malik AB: Decreased oxidant
buffering impairs NF-kappaB activation and ICAM-1 transcriptionnisms, the effects of p-cresol could be involved in the
in endothelial cells. Shock 15:11–15, 2001immune defect of CRF patients. 21. Thompson DC, Perera K, Fisher R, Brendel K: Cresol isomers:
Comparison of toxic potency in rat liver slices. Toxicol Appl Phar-
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